Impact on Optical Coherence Tomographic Coronary Findings of Fluvastatin Alone Versus Fluvastatin + Ezetimibe - 31/01/14
, Mitsuyasu Terashima, MD, Euihong Ko, MD, Daisuke Yokota, MD, Tsuyoshi Ito, MD, Tairo Kurita, MD, Tomohiko Teramoto, MD, Masashi Kimura, MD, Yoshihisa Kinoshita, MD, Etsuo Tsuchikane, MD, Yasushi Asakura, MD, Tetsuo Matsubara, MD, Takahiko Suzuki, MDAbstract |
Although lipid-lowering therapy with statin and ezetimibe has been reported to provide greater reduction in low-density lipoprotein cholesterol levels than statin monotherapy, the effect of supplemental therapy on plaque stabilization is yet to be fully elucidated. Cap thickness of fibroatheroma evaluated by optical coherence tomography (OCT) is a major determinant of vulnerable plaque. The primary objective of this study is to evaluate the effect of ezetimibe in addition to fluvastatin on the progression of coronary atherosclerotic plaque evaluated by OCT. Sixty-three patients with angina pectoris with intermediate, nonculprit, lipid-rich plaque lesions evaluated by OCT were enrolled. The patients were divided into 2 groups: ezetimibe (10 mg/day) + fluvastatin (30 mg/day), and fluvastatin (30 mg/day) alone, and serial OCT examinations were performed at baseline and 9-month follow-up. A total of 57 patients (ezetimibe + fluvastatin, n = 31; fluvastatin alone, n = 26) underwent serial OCT examinations. The change in low-density lipoprotein cholesterol level was significantly larger in the ezetimibe + fluvastatin group compared with fluvastatin-alone group (−34.0 ± 32.0 vs −8.3 ± 17.4 mg/dl, p <0.001). Fibrous cap thickness was significantly increased and the angle of the lipid plaque was significantly decreased in both groups. The change in the fibrous cap thickness was significantly greater in the ezetimibe + fluvastatin group (0.08 ± 0.08 mm vs 0.04 ± 0.06 mm, p <0.001). In conclusion, lipid-lowering therapy by ezetimibe + fluvastatin could increase the fibrous cap thickness of lipid-rich plaque compared with fluvastatin monotherapy.
Le texte complet de cet article est disponible en PDF.Plan
| See page 586 for disclosure information. |
Vol 113 - N° 4
P. 580-587 - février 2014 Retour au numéro
Article précédent
- Five-Year Follow-Up of Patients Treated for Coronary Artery Disease in the Face of an Increasing Burden of Co-Morbidity and Disease Complexity (from the NHLBI Dynamic Registry)
- Anna E. Bortnick, Kelly C. Epps, Faith Selzer, Saif Anwaruddin, Oscar C. Marroquin, Vankeepuram Srinivas, Elizabeth M. Holper, Robert L. Wilensky
- Continuous Venovenous Hemofiltration After Coronary Procedures for the Prevention of Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Renal Failure
- Carlo Guastoni, Nicoletta Bellotti, Fabrizio Poletti, Patrizia Covella, Barbara Gidaro, Antonella Stasi, Giovanni Seveso, Maurizio D'Urbano, Matteo Mariani, Stefano De Servi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?